OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 91 filers reported holding OVID THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,490,816 | +17.1% | 6,117,400 | 0.0% | 0.79% | +61.0% |
| Q2 2023 | $20,065,072 | +27.1% | 6,117,400 | 0.0% | 0.49% | -3.1% |
| Q1 2023 | $15,782,892 | +38.7% | 6,117,400 | 0.0% | 0.51% | +46.8% |
| Q4 2022 | $11,378,364 | +1.1% | 6,117,400 | 0.0% | 0.35% | +4.2% |
| Q3 2022 | $11,256,000 | -14.4% | 6,117,400 | 0.0% | 0.33% | -26.9% |
| Q2 2022 | $13,152,000 | -31.5% | 6,117,400 | 0.0% | 0.45% | -24.5% |
| Q1 2022 | $19,209,000 | -1.6% | 6,117,400 | +0.6% | 0.60% | -3.4% |
| Q4 2021 | $19,524,000 | -4.5% | 6,082,200 | 0.0% | 0.62% | -12.5% |
| Q3 2021 | $20,436,000 | -14.1% | 6,082,200 | 0.0% | 0.71% | -20.0% |
| Q2 2021 | $23,781,000 | -2.7% | 6,082,200 | 0.0% | 0.89% | -18.0% |
| Q1 2021 | $24,450,000 | – | 6,082,200 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |